These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25790163)

  • 1. Navigating the current landscape of clinical genetic testing for inherited retinal dystrophies.
    Lee K; Garg S
    Genet Med; 2015 Apr; 17(4):245-52. PubMed ID: 25790163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new landscape of retinal gene therapy.
    Ku CA; Pennesi ME
    Am J Med Genet C Semin Med Genet; 2020 Sep; 184(3):846-859. PubMed ID: 32888388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [RPE65-retinal Dystrophies: From the Spectrum of the Clinical Picture to Gene Therapy].
    Stingl K; Priglinger C
    Klin Monbl Augenheilkd; 2024 Mar; 241(3):257-258. PubMed ID: 38508213
    [No Abstract]   [Full Text] [Related]  

  • 4. RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec.
    Stingl K; Priglinger C; Herrmann P
    Klin Monbl Augenheilkd; 2024 Mar; 241(3):259-265. PubMed ID: 38508214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voretigene neparvovec-rzyl (Luxturna) for inherited retinal dystrophy.
    Med Lett Drugs Ther; 2018 Mar; 60(1543):53-55. PubMed ID: 29635265
    [No Abstract]   [Full Text] [Related]  

  • 6. Dog models for blinding inherited retinal dystrophies.
    Petersen-Jones SM; Komáromy AM
    Hum Gene Ther Clin Dev; 2015 Mar; 26(1):15-26. PubMed ID: 25671556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inherited retinal dystrophy: first results of RPE65 gene replacement therapy in Russia].
    Kadyshev VV; Zolnikova IV; Khalanskaya OV; Stepanova AA; Kutsev SI
    Vestn Oftalmol; 2022; 138(4):48-57. PubMed ID: 36004591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene.
    Chung DC; Bertelsen M; Lorenz B; Pennesi ME; Leroy BP; Hamel CP; Pierce E; Sallum J; Larsen M; Stieger K; Preising M; Weleber R; Yang P; Place E; Liu E; Schaefer G; DiStefano-Pappas J; Elci OU; McCague S; Wellman JA; High KA; Reape KZ
    Am J Ophthalmol; 2019 Mar; 199():58-70. PubMed ID: 30268864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Gene Therapy Treatments for Inherited Retinal Diseases.
    Bakall B; Hariprasad SM; Klein KA
    Ophthalmic Surg Lasers Imaging Retina; 2018 Jul; 49(7):472-478. PubMed ID: 30021033
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genetic diagnostic testing in inherited retinal dystrophies].
    Kohl S; Biskup S
    Klin Monbl Augenheilkd; 2013 Mar; 230(3):243-6. PubMed ID: 23208805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.
    Russell S; Bennett J; Wellman JA; Chung DC; Yu ZF; Tillman A; Wittes J; Pappas J; Elci O; McCague S; Cross D; Marshall KA; Walshire J; Kehoe TL; Reichert H; Davis M; Raffini L; George LA; Hudson FP; Dingfield L; Zhu X; Haller JA; Sohn EH; Mahajan VB; Pfeifer W; Weckmann M; Johnson C; Gewaily D; Drack A; Stone E; Wachtel K; Simonelli F; Leroy BP; Wright JF; High KA; Maguire AM
    Lancet; 2017 Aug; 390(10097):849-860. PubMed ID: 28712537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.
    Maguire AM; Bennett J; Aleman EM; Leroy BP; Aleman TS
    Mol Ther; 2021 Feb; 29(2):442-463. PubMed ID: 33278565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy.
    Kang C; Scott LJ
    Mol Diagn Ther; 2020 Aug; 24(4):487-495. PubMed ID: 32535767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RPE65-related retinal dystrophy: Mutational and phenotypic spectrum in 45 affected patients.
    Lopez-Rodriguez R; Lantero E; Blanco-Kelly F; Avila-Fernandez A; Martin Merida I; Del Pozo-Valero M; Perea-Romero I; Zurita O; Jiménez-Rolando B; Swafiri ST; Riveiro-Alvarez R; Trujillo-Tiebas MJ; Carreño Salas E; García-Sandoval B; Corton M; Ayuso C
    Exp Eye Res; 2021 Nov; 212():108761. PubMed ID: 34492281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific gene therapy for hereditary retinal dystrophies - an update].
    Stieger K; Lorenz B
    Klin Monbl Augenheilkd; 2014 Mar; 231(3):210-5. PubMed ID: 24327302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive genic and allelic heterogeneity underlying inherited retinal dystrophies in Mexican patients molecularly analyzed by next-generation sequencing.
    Zenteno JC; García-Montaño LA; Cruz-Aguilar M; Ronquillo J; Rodas-Serrano A; Aguilar-Castul L; Matsui R; Vencedor-Meraz CI; Arce-González R; Graue-Wiechers F; Gutiérrez-Paz M; Urrea-Victoria T; de Dios Cuadras U; Chacón-Camacho OF
    Mol Genet Genomic Med; 2020 Jan; 8(1):. PubMed ID: 31736247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of
    Kahraman NS; Öner A; Özkul Y; Dündar M
    Turk J Ophthalmol; 2022 Aug; 52(4):270-275. PubMed ID: 36017377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral Subretinal Voretigene Neparvovec-rzyl (Luxturna) Gene Therapy.
    Weng CY
    Ophthalmol Retina; 2019 May; 3(5):450. PubMed ID: 31044739
    [No Abstract]   [Full Text] [Related]  

  • 19. Retinal dystrophies and gene therapy.
    Sundaram V; Moore AT; Ali RR; Bainbridge JW
    Eur J Pediatr; 2012 May; 171(5):757-65. PubMed ID: 22080959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials.
    Maguire AM; Russell S; Wellman JA; Chung DC; Yu ZF; Tillman A; Wittes J; Pappas J; Elci O; Marshall KA; McCague S; Reichert H; Davis M; Simonelli F; Leroy BP; Wright JF; High KA; Bennett J
    Ophthalmology; 2019 Sep; 126(9):1273-1285. PubMed ID: 31443789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.